An Exploratory Factor Analysis of a Brief Self-Report Scale to Detect Neurocognitive Impairment Among Participants Enrolled in Methadone Maintenance Therapy.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Substance Abuse Treatment

• Publication date

  2016-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.jsat.2016.01.002PMID 26879859PMCID PMC4775373
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sex-Related Differences in Self-Reported Neurocognitive Impairment among High-Risk Cocaine Users in Methadone Maintenance Treatment Program

  2015influential reference
• Challenges in managing HIV in people who use drugs

  2015cited by this paper
• Cognitive Impairment in Cocaine Users is Drug-Induced but Partially Reversible: Evidence from a Longitudinal Study

  2014cited by this paper
• Evidence of specific cognitive deficits in patients with chronic low back pain under long-term substitution treatment of opioids.

  2014influential reference
• A Randomized Controlled Trial of the Community-Friendly Health Recovery Program (CHRP) Among High-Risk Drug Users in Treatment

  2013cited by this paper
• Characterizing the cognitive effects of cocaine: a comprehensive review.

  2013cited by this paper
• Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis.

  2012cited by this paper
• The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS

  2012influential reference
• HIV-1 infection and cognitive impairment in the cART era: a review.

  2011cited by this paper
• Neurocognitive Impairment and HIV Risk Factors: A Reciprocal Relationship

  2010influential reference
• Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.

  2010cited by this paper
• The prospective relationships among intrinsic motivation, neurocognition, and psychosocial functioning in schizophrenia.

  2010cited by this paper
• Impairment of cognitive abilities and decision making after chronic use of alcohol: the impact of multiple detoxifications.

  2009cited by this paper
• Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research.

  2009cited by this paper
• Neuropsychological Functioning of Opiate-Dependent Patients: A Nonrandomized Comparison of Patients Preferring either Buprenorphine or Methadone Maintenance Treatment

  2008cited by this paper
• Alcohol consumption, mild cognitive impairment, and progression to dementia

  2007cited by this paper
• Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change.

  2006cited by this paper
• Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls

  2006influential reference
• Effects of Moderate Alcohol Consumption on Cognitive Function in Women

  2006cited by this paper
• Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers.

  2005cited by this paper
• Clinical Implications and Methodological Challenges in the Study of the Neuropsychological Correlates of Cannabis, Stimulant, and Opioid Abuse

  2004cited by this paper
• Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review.

  2003cited by this paper
• Intervening Effectively with Drug Abusers Infected with HIV: Taking into Account the Potential for Cognitive Impairment

  2003cited by this paper
• Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users.

  2002cited by this paper
• Cognitive impairment in methadone maintenance patients.

  2002cited by this paper
• Cognitive impairment among methadone maintenance patients.

  2000cited by this paper
• Effects of executive function impairment on change processes and substance use outcomes in 12-step treatment.

  1999cited by this paper
• Neurocognitive dysfunction in dually-diagnosed patients: a potential roadblock to motivating behavior change.

  1999cited by this paper
• Ability to counselors to detect cognitive impairment among substance-abusing patients: an examination of diagnostic efficiency.

  1997influential reference
• Principal-components analysis and exploratory and confirmatory factor analysis.

  1995cited by this paper
• Validity and reliability of the revised Neuropsychological Impairment Scale (NIS).

  1993cited by this paper
• NEUROCOGNITIVE ASPECTS OF SUBSTANCE ABUSE TREATMENT: A PSYCHOTHERAPIST'S PRIMER

  1993cited by this paper
• Sensitivity and specificity of the Neuropsychological Impairment Scale (NIS).

  1984cited by this paper
• Validity and reliability of the Neuropsychological Impairment Scale (NIS).

  1984cited by this paper
• Neuropsychological impairment scale (NIS): initial validation study using trailmaking test (A & B) and WAIS digit symbol (scaled score) in a mixed grouping of psychiatric, neurological, and normal patients.

  1983cited by this paper
• Bmc Clinical Pharmacology Methadone vs. Buprenorphine/naloxone during Early Opioid Substitution Treatment: a Naturalistic Comparison of Cognitive Performance Relative to Healthy Controls

  year unknowninfluential reference

• Occurrence of Opioid-Related Neurocognitive Symptoms Associated With Long-term Opioid Therapy

  2024cites this paper
• Testing the feasibility, acceptability, and preliminary efficacy of integrating accommodation strategies into an HIV prevention intervention for people who inject drugs with cognitive dysfunction.

  2024cites this paper
• Social and cognitive determinants of medications for opioid use disorder outcomes: A systematic review using a social determinants of health framework

  2024influential citation
• Latent profile analysis of data from the brief inventory of neurocognitive impairment (BINI) to develop neuro-cognitive profiles among opioid-dependent patients in drug treatment

  2022cites this paper
• Integrating Cognitive Dysfunction Accommodation Strategies into an HIV Prevention Session: A 2-Arm Pilot Feasibility Study

  2022cites this paper
• Developing a cognitive dysfunction risk score for use with opioid-dependent persons in drug treatment.

  2021cites this paper
• Security aspects at airports and the willingness of passengers to travel abroad during a pandemic of the COVID-19 virus

  2021cites this paper
• Association between the brief inventory of neurocognitive impairment (BINI) and objective cognitive testing among persons with opioid use disorders in drug treatment

  2020influential citation
• Cognitive profiles in persons with opioid use disorder enrolled in methadone treatment

  2020cites this paper
• Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.

  2019cites this paper
• Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV‐Infected Drug Users in Treatment

  2017cites this paper
• An explanatory factor analysis of a brief self-report scale to detect neurocognitive impairment among HIV-positive men who have sex with men and transgender women in Peru

  2017cites this paper
• The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis

  2017cites this paper
• Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment.

  2017cites this paper
• A Self-report Measure to Detect Neurocognitive Impairment Among Incarcerated People Living with HIV in Malaysian Context: an Exploratory Factor Analysis

  2017cites this paper
• Intent to Use Preexposure Prophylaxis (PrEP), HIV Risk Behaviors, and Self‐Report Neurocognitive Symptoms by High‐Risk Drug Users: A Mediation Analysis

  2017cites this paper
• Interest in use of mHealth technology in HIV prevention and associated factors among high-risk drug users enrolled in methadone maintenance program

  2017cites this paper
• Acceptability and Correlates of Pre-Exposure Prophylaxis Use for HIV Prevention among High-Risk Drug Users in Treatment

  2017cites this paper
• Examining the Acceptability of mHealth Technology in HIV Prevention Among High-Risk Drug Users in Treatment

  2017cites this paper
• Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in Treatment

  2016cites this paper